Manufacturers Life Insurance Company, The Curis Inc Transaction History

Manufacturers Life Insurance Company, The

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.71 - $2.43 $26,596 - $91,027	-37,460 Closed	0 $0
Q1 2022 Aug 11, 2023	BUY	$2.31 - $5.13 $86,532 - $192,169	37,460 New	37,460 $89,000
Q1 2022 May 20, 2022	SELL	$2.31 - $5.13 $20,545 - $45,626	-8,894 Reduced 19.19%	37,460 $89,000
Q4 2021 Feb 16, 2022	BUY	$4.45 - $8.09 $3,395 - $6,172	763 Added 1.67%	46,354 $221,000
Q3 2021 Nov 12, 2021	SELL	$6.94 - $8.85 $26,260 - $33,488	-3,784 Reduced 7.66%	45,591 $357,000
Q2 2021 Aug 12, 2021	BUY	$7.45 - $16.27 $367,843 - $803,331	49,375 New	49,375 $398,000
Q3 2018 Nov 14, 2018	SELL	$1.38 - $1.94 $1,477 - $2,077	-1,071 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$1.73 - $3.35 $1,852 - $3,587	1,071 New	1,071 $2,000

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $393M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.